BETTERLIFE PHARMA INC BETRF

$0.21 -3.73% at last close

Recent SEC Filings

FormDescriptionFiledDocument
6-K FORM 6-K 2026-08-05 View →
6-K FORM 6-K 2026-06-26 View →
6-K FORM 6-K 2026-06-25 View →
20-F FORM 20-F 2026-06-01 View →
6-K FORM 6-K 2026-04-13 View →
6-K FORM 6-K 2025-09-29 View →
6-K FORM 6-K 2025-07-28 View →
6-K FORM 6-K 2025-06-27 View →
6-K FORM 6-K 2025-06-23 View →
20-F FORM 20-F 2025-06-02 View →
6-K FORM 6-K 2025-05-30 View →
6-K FORM 6-K 2025-05-07 View →
6-K FORM 6-K 2025-04-07 View →
6-K FORM 6-K 2024-12-31 View →
6-K FORM 6-K 2024-12-09 View →
6-K FORM 6-K 2024-10-15 View →
6-K FORM 6-K 2024-09-26 View →
6-K FORM 6-K 2024-08-29 View →
6-K FORM 6-K 2024-08-08 View →
6-K FORM 6-K 2024-07-15 View →
6-K FORM 6-K 2024-06-28 View →
6-K FORM 6-K 2024-06-17 View →
20-F FORM 20-F 2024-05-30 View →
6-K FORM 6-K 2024-05-14 View →
6-K FORM 6-K 2024-05-06 View →
6-K FORM 6-K 2024-04-11 View →
6-K FORM 6-K 2024-04-04 View →
6-K FORM 6-K 2024-03-05 View →
6-K FORM 6-K 2024-01-02 View →
6-K FORM 6-K 2023-12-29 View →
6-K FORM 6-K 2023-12-18 View →
6-K FORM 6-K 2023-11-30 View →
6-K FORM 6-K 2023-09-29 View →
6-K FORM 6-K 2023-09-28 View →
6-K FORM 6-K 2023-09-05 View →
6-K FORM 6-K 2023-07-13 View →
6-K FORM 6-K 2023-06-28 View →
6-K FORM 6-K 2023-06-28 View →
6-K FORM 6-K 2023-06-09 View →
20-F FORM 20-F 2023-05-31 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.21
Market Cap
—
52-Week Range
$0.03 – $0.33
Average Volume
154K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.